TScan Therapeutics Says CFO Brian Silver Will Be Leaving Company, Effective July 21, 2023, To Pursue New Opportunity
Portfolio Pulse from Benzinga Newsdesk
TScan Therapeutics announced that CFO Brian Silver will be leaving the company effective July 21, 2023, to pursue a new opportunity. The company has initiated a search for a new CFO.
June 29, 2023 | 11:08 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TScan Therapeutics' CFO Brian Silver is leaving the company in 2023. This could lead to potential instability in the company's financial management.
The departure of a CFO can lead to potential instability in a company's financial management, especially if a suitable replacement is not found quickly. This could negatively impact the company's stock in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100